India News | Surat Emerges as Lifeline for Hemophilia Patients Across India
Get latest articles and stories on India at LatestLY. The Hemophilia Care Centre at New Civil Hospital in Surat is emerging as a major lifeline for patients suffering from hemophilia, offering free and advanced treatment to hundreds from across India.
Surat (Gujarat) [India], March 30 (ANI): The Hemophilia Care Centre at New Civil Hospital in Surat is emerging as a major lifeline for patients suffering from hemophilia, offering free and advanced treatment to hundreds from across India.
Established in 2015, the centre has registered over 650 patients and is increasingly becoming a hub for complex procedures, including major joint surgeries. Patients from not only Gujarat but also other states are travelling to Surat for treatment.
Hemophilia, a genetic disorder that affects the blood's ability to clot, can lead to severe disability if left untreated. At the Surat centre, patients receive comprehensive care including free factor therapy, diagnostic services, physiotherapy, and surgical interventions, ensuring timely treatment and improved quality of life.
Families of patients have highlighted the accessibility of services at the facility. A patient's mother said her child has been receiving treatment for the past 16 years and praised the centre for being operational round-the-clock, allowing patients to seek care at any time.
Also Read | Petrol, Diesel Stocks Adequate, No Dry-Outs at LPG Agencies, Says Government.
Another patient from Bihar said that the cost of treatment in private hospitals is unaffordable, particularly the expensive clotting factors, and expressed gratitude for the free services provided at the centre.
Doctors and officials at the hospital underlined the importance of timely treatment. Civil Superintendent Dharitri Parmar noted that delayed treatment can lead to disability and affect a patient's ability to live independently, while timely access to clotting factors significantly improves their lifestyle.
Hospital authorities also highlighted the high cost involved in treating hemophilia. Resident Medical Officer Ketan Nayak said that the centre incurs an average annual expenditure of Rs 4-5 crore, funded by the Gujarat government. He added that clotting factors, which are crucial for surgeries, are procured centrally through the Government e-Marketplace (GeM), and treatment for a single patient can sometimes cost between Rs 70 lakh to Rs 2 crore.
Officials at the Hemophilia Care Centre stated that many patients who arrive with severe mobility issues are able to walk again after treatment, despite being told elsewhere to live with their condition.
With free treatment and government support, Surat is steadily becoming a beacon of hope for hemophilia patients who previously had limited access to affordable care. (ANI)
(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)